Vertex (NASDAQ:VERX) Stock

Vertex

Vertex Inc is a provider of tax technology and services. Its software, content, and services help customers stay in compliance with indirect taxes that occur in taxing jurisdictions all over the world. Vertex provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions such as tax determination, Tax Data Management, document management, and compliance and reporting among others. The company derives revenue from software subscriptions.

Vertex Inc

News

General

NCNO

Sandbox Banking's Glyue Introduced In The Zoom App Marketplace

United Maritime (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USEA#NASDAQ">USEA</a>) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.41) by 80.49 percent. This is a 14.29 percent decrease over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $10.80 million which beat the analyst consensus estimate of $9.50 million by 13.68 percent. This is a 6.90 percent decrease over sales of $11.60 million the same period last year.

Earnings

Earnings Beats

USEA

United Maritime Q4 2024 Adj EPS $(0.08) Beats $(0.41) Estimate, Sales $10.80M Beat $9.50M Estimate

Biotech

VRAX

Virax Biolabs Enrolls First Patients In Its UK Based Clinical Study Assessing T Cell Dysfunction In Post-acute Infection Syndromes

Stoke Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STOK#NASDAQ">STOK</a>) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.53) by 66.04 percent. This is a 70 percent increase over losses of $(0.60) per share from the same period last year. The company reported quarterly sales of $22.60 million which beat the analyst consensus estimate of $4.28 million by 428.04 percent. This is a 706.85 percent increase over sales of $2.80 million the same period last year.

STOK

Stoke Therapeutics Q4 2024 GAAP EPS $(0.18) Beats $(0.53) Estimate, Sales $22.60M Beat $4.28M Estimate

Needham analyst Joseph Stringer maintains Rhythm Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYTM#NASDAQ">RYTM</a>) with a Buy and raises the price target from $64 to $66.

Price Target

Analyst Ratings

RYTM

Needham Maintains Buy on Rhythm Pharmaceuticals, Raises Price Target to $66

Chinese EV maker&nbsp;XPeng&nbsp;Inc&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) shares are trading lower premarket on Tuesday. The company reported&nbsp;fiscal&nbsp;fourth-quarter sales growth of&nbsp;23.4%&nbsp;year-on-year to 16.11 billion Chinese Yuan&nbsp;($2.21&nbsp;billion), topping the&nbsp;consensus estimate <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/g44372075/xpeng-reports-fourth-quarter-and-fiscal-year-2024-unaudited-financial-results" rel="noreferrer noopener">of&nbsp;16.02 billion Chinese Yuan</a>.&nbsp;
Total revenues increased 59.4% sequentially in the quarter. The Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) rival's quarterly vehicle deliveries increased 52.1% Y/Y to 91,507. XPeng's physical sales network had 690 stores, covering 226 cities as of December 31, 2024.
XPeng's self-operated charging station network reached 1,920 stations as of December 31, 2024. Revenues from vehicle sales increased 20.0% Y/Y to 14.67 billion Chinese Yuan ($2.01 billion) on higher deliveries.
Gross margin was 14.4% versus 6.2% a year ago. Vehicle margin was 10.0% versus 4.1% a year ago, primarily attributable to the cost reduction. Operating loss for the quarter was 1.56 billion Chinese Yuan ($0.21 billion). 
Adjusted net loss per ADS of 1.47 Chinese Yuan missed the analyst consensus estimate for a loss of 1.35 Chinese Yuan. In USD terms, the adjusted earnings <a href="https://www.benzinga.com/earnings" target="_blank" rel="noreferrer noopener">per ADS was a loss of 20 cents</a> in-line with the consensus of 20 cents loss.
The&nbsp;company held&nbsp;$5.75 billion&nbsp;in cash and equivalents&nbsp;as of December 31, 2024.
Read: <a target="_blank" href="https://www.benzinga.com/25/03/44240449/tesla-rival-xpeng-eyes-138-billion-investment-in-humanoid-robots-says-chinese-state-media" rel="noreferrer noopener">Tesla Rival XPeng Eyes $13.8 Billion Investment In Humanoid Robots, Says Chinese State Media</a>
Chairman and CEO of XPENG, Xiaopeng He, highlighted the company&#8217;s strategic positioning to expand its market share in the Smart EV sector both in China and internationally.
He emphasized that AI will play a crucial role in advancing L3 and L4 autonomous driving within the automotive industry. The company&#8217;s goal is to establish XPENG as a globally recognized AI-driven automotive company and a smart technology brand that resonates with users worldwide.
Outlook: XPENG projects first-quarter vehicle deliveries between 91,000 and 93,000, reflecting <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">a surge of 317% to 326.8% Y/Y</a>.
The company anticipates revenue of 15 billion Chinese Yuan to 15.7 billion Chinese Yuan, vs. the consensus of 14.684 billion Chinese Yuan.
Investors can gain exposure to the stock via&nbsp;VanEck Low Carbon Energy ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMOG#NYSE">SMOG</a>) and Invesco WilderHill Clean Energy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBW#NYSE">PBW</a>).
Price Action: XPEV shares are down 0.49% at $24.44 premarket at the last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44267567/xpeng-hesai-group-kohls-groupon-and-tesla-why-these-5-stocks-are-on-investors-radars-today" target="_blank" rel="noreferrer noopener">Xpeng, Hesai Group, Kohl&#8217;s, Groupon, And Tesla: Why These 5 Stocks Are On Investors&#8217; Radars Today</a></li>
</ul>
Image via Shutterstock.

Equities

Large Cap

Guidance

Movers

PowerShares Exchange Traded Fund Trust WilderHill Clean Energy Portfolio

SMOG

TSLA

XPEV

Tesla's China Rival XPeng Delivers Over 91,500 EVs In Q4, Eyes Massive Growth In Q1

UBS analyst Brian Meredith upgrades Willis Towers Watson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>) from Neutral to Buy and raises the price target from $344 to $395.

Upgrades

UBS Upgrades Willis Towers Watson to Buy, Raises Price Target to $395

HC Wainwright &amp; Co. analyst Robert Burns maintains Black Diamond Therapeutic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDTX#NASDAQ">BDTX</a>) with a Buy and raises the price target from $11 to $12.

BDTX

HC Wainwright & Co. Maintains Buy on Black Diamond Therapeutic, Raises Price Target to $12

ADTX

Appili Therapeutics Submits Applications For Four New Federal Funding Opportunities

Barclays analyst Lauren Lieberman downgrades PepsiCo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>) from Overweight to Equal-Weight and lowers the price target from $168 to $156.

Downgrades

Barclays Downgrades PepsiCo to Equal-Weight, Lowers Price Target to $156

LASE

Laser Photonics Enhances Gantry Laser Technology In Partnership With Subsidiary Control Micro Systems

Mizuho analyst Maheep Mandloi initiates coverage on Bloom Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) with a Neutral rating and announces Price Target of $28.

Initiation

Mizuho Initiates Coverage On Bloom Energy with Neutral Rating, Announces Price Target of $28

OneConnect Financial Tech (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OCFT#NYSE">OCFT</a>) reported quarterly losses of $(2.18) per share. This is a 600.96 percent decrease over losses of $(0.31) per share from the same period last year. The company reported $57.78 million in sales this quarter. This is a 54.97 percent decrease over sales of $128.31 million the same period last year.

OCFT

OneConnect Financial Tech Q4 EPS $(2.18) Down From $(0.31) YoY, Sales $57.78M Down From $128.31M YoY

Jefferies analyst Edison Lee upgrades GDS Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDS#NASDAQ">GDS</a>) from Hold to Buy and announces $45 price target.

Jefferies Upgrades GDS Holdings to Buy, Announces $45 Price Target

Jefferies analyst Julien Dumoulin-Smith downgrades TPI Composites (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPIC#NASDAQ">TPIC</a>) from Hold to Underperform and lowers the price target from $2.3 to $0.5.

TPIC

Jefferies Downgrades TPI Composites to Underperform, Lowers Price Target to $0.5

TIGR: 8% &#x7C; <a href="https://www.benzinga.com//node/44371198">UP Fintech Holding Q4 Adj $0.17 Beats $0.11 Estimate, Sales $124.10M Beat $97.00M Estimate</a>
&nbsp;
RL: 3% &#x7C; <a href="https://www.benzinga.com//node/44373413">Ralph Lauren shares are trading higher after Goldman Sachs upgraded the stock from Neutral to Buy and raised its price target from $280 to $286.</a>
&nbsp;
BBAI: -9% &#x7C; <a href="https://www.benzinga.com//node/44373404">BigBear.ai shares are trading lower after the company said it identified the need to restate certain prior financial statements.</a>

Trading Ideas

BBAI

TIGR

Market-Moving News for March 18th

DPRO

Draganfly Completes Demonstration For Simulated Delivery Of Medical Supplies With Massachusetts Department of Transportation

HC Wainwright &amp; Co. analyst Robert Burns maintains OnKure Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKUR#NASDAQ">OKUR</a>) with a Buy and lowers the price target from $40 to $34.

OKUR

HC Wainwright & Co. Maintains Buy on OnKure Therapeutics, Lowers Price Target to $34

Tech

VERI

Veritone's AI solutions And Software Added To Carahsoft Canada's Supply Arrangement For SaaS Government of Canada Method Of Supply

Evercore ISI Group analyst Amit Daryanani maintains Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) with a Outperform and raises the price target from $260 to $275.

AAPL

Evercore ISI Group Maintains Outperform on Apple, Raises Price Target to $275

Press Releases

Vertex Global Survey Finds Half of Organizations Lagging in Tax and Finance Automation

Economics

Vertex Holiday Shopping Survey Emphasizes the Crucial Role of Tax Automation

Vertex to Present at Wells Fargo 8th Annual TMT Conference

Vertex Named a Leader in the 2024 IDC MarketScape for Worldwide SaaS and Cloud-Enabled Tax Automation Software for Enterprise, SMB and VAT

Vertex Recognized in Built In's Esteemed 2025 Best Places to Work Awards

Vertex to Announce Fourth Quarter 2024 Financial Results on Thursday, February 27, 2025

Comments

Vertex

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL